Hunan TV Reports on Xianshi Pharmaceutical’s Intelligent Oseltamivir Phosphate Granule Production Line
Release date:
2025-02-14
CHANGSHA, Feb 14, 2025 — Hunan Xianshi Pharmaceutical Co., Ltd. is accelerating digital transformation and smart manufacturing development amid national low-carbon and new-industry policy initiatives. On February 13, Hunan TV covered the company’s intelligent production line for oseltamivir phosphate granules during a live news report.
In recent years, central authorities have rolled out supportive policies to advance industrial and information technology equipment upgrading. Hunan Province has pushed forward the Ten-Thousand Enterprises Development Program to promote industrial digitalization and intelligent renovation across local manufacturers.
Industrial equipment upgrades are designed to expand production capacity and investment, as well as foster sound economic growth via advanced technologies, processes and manufacturing methods.
At Xianshi Pharmaceutical’s production workshop, newly installed automatic equipment is running at full capacity, with existing orders scheduled for fulfillment through June.
For its anti-influenza oseltamivir granule line, daily output has risen from 6,000 bottles to 30,000 bottles, marking a five-fold productivity growth.
A newly deployed production management information system supports real-time monitoring of each workshop station and automatic calculation of yield loss caused by abnormal production conditions.
Pan Manyi, General Manager of Hunan Xianshi Pharmaceutical, stated that following the construction of the company’s second-phase project, the firm plans to invest a minimum of RMB 50 million in equipment upgrades within the year to further lift overall production efficiency.
Supported by national industrial upgrading policies, Xianshi Pharmaceutical has accelerated intelligent renovation. Automated production systems have greatly improved operational efficiency, most evidently on the oseltamivir production line with five times higher daily output.
The newly built management IT system realizes full-process real-time monitoring and refined control, effectively cutting production wastage. Together with a planned RMB 50 million equipment upgrade investment in 2025, the company aims to strengthen its market competitiveness and set a reference for smart transformation in the domestic pharmaceutical industry.
Moving forward, Xianshi Pharmaceutical will keep focusing on technological innovation and digital upgrading in line with national industrial guidelines, striving to fuel high-quality development of the pharmaceutical industry.
Latest News
Share to
Hotline
Address
No. 19, Baizhu Road, Economic and Technological Development Zone, Liuyang City, Changsha, Hunan, China
Copyright © HUNAN XIANSHI PHARMACEUTICAL CO., LTD.
This site supports IPv4 IPv6 .